SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-064413
Filing Date
2010-03-23
Accepted
2010-03-23 16:04:49
Documents
9
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 892711
2 EMPLOYMENT AGREEMENT dex1018.htm EX-10.18 20862
3 FORM OF STOCK OPTION AGREEMENT dex1019.htm EX-10.19 27259
4 CONSENT OF VASQUEZ & COMPANY LLP dex231.htm EX-23.1 2372
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 6469
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 6459
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 3244
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 3235
9 GRAPHIC g61138g40t42.jpg GRAPHIC 17383
  Complete submission text file 0001193125-10-064413.txt   988156
Mailing Address 2595 JASON COURT OCEANSIDE CA 92056
Business Address 2595 JASON COURT OCEANSIDE CA 92056 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51891 | Film No.: 10699421
SIC: 2834 Pharmaceutical Preparations